Haha! At least my predictions are serious.

First 6 Last

Share
Profile

Follow
josiejow37

280 Posts.

95

08/03/24

13:14

Post #: 72813814
Share

Originally posted by goedy: ↑

And my predictions are.......

1. 12 - 18 months time RHY will put their hands out for more money

2. Not one Colostat kit will be sold, anywhere. Not UK, not Europe, not US and obviously not Aus

3. The TGA application will remain unsubmitted. Heaven knows why, how long does it take to prepare blank documents?

4. The share price may move a little with each announcment, given the size of its drop, BUT the market is well aware of the bullshit this company thrives on and any movement will minimal and not be sustained.

5. Competition for Colostat will only INCREASE as more labs tool up with DNA testing equipment as it becomes mandatory if the lab wants to remain viable. DNA testing costs will fall. And given the vastly superior results from DNA testing Colostat will never get a foothold anywhere.

6. RHY management will continue travelling to conferences throughout the world, on your generous dollar, to bark their credentials to people who were clearly not interested before and are even less interested now.

7. There will be no take over offer for a company with ONE test, the full results of which have not been released, are way worse than DNA testing, miserably failed their TGA application and have never sold a single kit in 3 years.

Expand

Haha! At least my predictions are serious.

RHY Price at posting: 9.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 32 more messages in this thread...

First 6 Last

Add RHY (ASX) to my watchlist

(20min delay)
Last 6.0¢		Change -0.001(1.64%)		Mkt cap ! $14.91M

Open	High	Low	Value	Volume
6.1¢	6.2¢	6.0¢	$7.244K	119.2K

Buyers (Bids)

No.	Vol.	Price($)
1	54512	6.0¢

Sellers (Offers)

Price($)	Vol.	No.
6.2¢	144742	1

View Market Depth

No.	Vol.	Price($)
1	54512	0.060
3	26241	0.058
1	62500	0.056
1	54545	0.055
1	59995	0.050

Price($)	Vol.	No.
0.062	144742	1
0.063	34	1
0.065	9750	1
0.066	80000	1
0.070	75394	2

Last trade - 15.39pm 09/07/2024 (20 minute delay)

RHY (ASX) Chart

Haha! At least my predictions are serious.

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Haha! At least my predictions are serious.

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News